[The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
Olsson
Anders G
AG
Institutionen för medicin och vård, internmedicin, Berzelius Science Park, Universitets-sjukhuset, Linköping. andol@imv.liu.se
D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D017410:Practice Guidelines as Topic; D011758:Pyrroles / Q000008:administration & dosage*; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin